The MOBID ‐2 pain scale: Reliability and responsiveness to pain in patients with dementia

Abstract

Abstract

          Background
          
            M
            obilization‐
            O
            bservation‐
            B
            ehavior‐
            I
            ntensity‐
            D
            ementia‐2 (
            MOBID
            ‐2) pain scale is a staff‐administered pain tool for patients with dementia. This study explores
            MOBID
            ‐2's test–retest reliability, measurement error and responsiveness to change.
          
        
        
          Methods
          
            Analyses are based upon data from a cluster randomized trial including 352 patients with advanced dementia from 18 Norwegian nursing homes. Test–retest reliability between baseline and week 2 (
            n
             = 163), and weeks 2 and 4 (
            n
             = 159) was examined in patients not expected to change (controls), using intraclass correlation coefficient (
            ICC
            2.1
            ), standard error of measurement (
            SEM
            ) and smallest detectable change (
            SDC
            ). Responsiveness was examined by testing six priori‐formulated hypotheses about the association between change scores on
            MOBID
            ‐2 and other outcome measures.
          
        
        
          Results
          
            ICCs
            of the total
            MOBID
            ‐2 scores were 0.81 (0–2 weeks) and 0.85 (2–4 weeks).
            SEM
            and
            SDC
            were 1.9 and 3.1 (0–2 weeks) and 1.4 and 2.3 (2–4 weeks), respectively. Five out of six hypotheses were confirmed:
            MOBID
            ‐2 discriminated (
            p
             < 0.001) between change in patients with and without a stepwise protocol for treatment of pain (
            SPTP)
            . Moderate association (
            r
             = 0.35) was demonstrated with
            C
            ohen‐
            M
            ansfield
            A
            gitation
            I
            nventory, and no association with
            M
            ini‐
            M
            ental
            S
            tate
            E
            xamination,
            F
            unctional
            A
            ssessment
            S
            taging and
            A
            ctivity of
            D
            aily
            L
            iving. Expected associations between change scores of
            MOBID
            ‐2 and
            N
            europsychiatric
            I
            nventory –
            N
            ursing
            H
            ome version were not confirmed.
          
        
        
          Conclusion
          
            The
            SEM
            and
            SDC
            in connection with the
            MOBID
            ‐2 pain scale indicate that the instrument is responsive to a decrease in pain after a
            SPTP
            . Satisfactory test–retest reliability across test periods was demonstrated. Change scores ≥ 3 on total and subscales are clinically relevant and are beyond measurement error.

Attachments

• ejp0018-1419.pdf
• Husebo et al. - 2014 - The MOBID.pdf